Clinical Trials Browser

OTHER × Hormone Refractory Prostate Cancer × Docetaxel × Clear all

NCT02208583 2014-08-05

Molecular Phenotype Changes and Personalized Treatment for CRPC

Phase NA Unknown

Hormone Refractory Prostate Cancer

NCT00313482 2012-05-11

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Phase 2 Terminated

Hormone Refractory Prostate Cancer

NCT00795171 2010-08-18

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Phase 2 Unknown

Hormone Refractory Prostate Cancer